Acquired resistance to venetoclax plus azacitidine in acute myeloid leukemia: In vitro models and mechanisms-Reference-Cited by-同舟云学术

Acquired resistance to venetoclax plus azacitidine in acute myeloid leukemia: In vitro models and mechanisms

Published:2023-10 Issue: Volume:216 Page:115759
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Carter Jenna L.,Su Yongwei,Qiao Xinan,Zhao Jianlei,Wang Guan,Howard Mackenzie,Edwards Holly,Bao Xun,Li Jing,Hüttemann Maik,Yang Jay,Taub Jeffrey W.,Ge Yubin

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference75 articles.

1. SEER Cancer Stat Facts: Acute Myeloid Leukemia Bethesda, MD: National Cancer Institute; [Available from: https://seer.cancer.gov/statfacts/html/amyl.html].

2. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century;Pulte;Blood Cancer J.,2020

3. The treatment of elderly patients with acute myeloid leukemia;Krug;Deutsches Arzteblatt Int.,2011

5. Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia;Saliba;Cancer drug resistance (Alhambra, Calif).,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in biomarkers, therapeutics, and associated challenges in acute myeloid leukemia;Annals of Hematology;2024-08-29

2. Capivasertib reverses chemotherapy-induced esophageal cancer resistance via inhibiting Akt-associated Mcl-1 upregulation;Heliyon;2024-07

3. Venetoclax Resistance in Acute Myeloid Leukemia;Cancers;2024-03-08

4. Crosstalk between autophagy and metabolism: implications for cell survival in acute myeloid leukemia;Cell Death Discovery;2024-01-24